# Effects of Epidermal Growth Factor Receptor Inhibitor Therapy in the Skin of Cancer Patients

> **NCT00483457** · — · COMPLETED · sponsor: **Vanderbilt-Ingram Cancer Center** · enrollment: 33 (actual)

## Conditions studied

- Solid Tumor

## Interventions

- **DRUG:** enzyme inhibitor therapy
- **GENETIC:** protein expression analysis
- **OTHER:** immunohistochemistry staining method
- **OTHER:** laboratory biomarker analysis
- **PROCEDURE:** biopsy

## Key facts

- **NCT ID:** NCT00483457
- **Lead sponsor:** Vanderbilt-Ingram Cancer Center
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2006-02
- **Primary completion:** 2008-11
- **Final completion:** 2008-11
- **Target enrollment:** 33 (ACTUAL)
- **Last updated:** 2012-09-03

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00483457

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00483457, "Effects of Epidermal Growth Factor Receptor Inhibitor Therapy in the Skin of Cancer Patients". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT00483457. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*